Transduction by adeno-associated virus vectors in the rabbit airway: efficiency, persistence, and readministration.
about
The RD114/simian type D retrovirus receptor is a neutral amino acid transporterCircular intermediates of recombinant adeno-associated virus have defined structural characteristics responsible for long-term episomal persistence in muscle tissue.Adeno-associated virus type 6 (AAV6) vectors mediate efficient transduction of airway epithelial cells in mouse lungs compared to that of AAV2 vectorsAdeno-associated virus serotype 2 induces cell-mediated immune responses directed against multiple epitopes of the capsid protein VP1The structure of adeno-associated virus serotype 3B (AAV-3B): Insights into receptor binding and immune evasionStructure–function analysis of receptor-binding in adeno-associated virus serotype 6 (AAV-6)Structure of adeno-associated virus-2 in complex with neutralizing monoclonal antibody A20Designer gene delivery vectors: molecular engineering and evolution of adeno-associated viral vectors for enhanced gene transferIntraocular route of AAV2 vector administration defines humoral immune response and therapeutic potentialLimitations of encapsidation of recombinant self-complementary adeno-associated viral genomes in different serotype capsids and their quantitationAdeno-associated virus vectors and hematologyStriatal readministration of rAAV vectors reveals an immune response against AAV2 capsids that can be circumvented.Long-term efficacy following readministration of an adeno-associated virus vector in dogs with glycogen storage disease type IaImmune responses to AAV in canine muscle monitored by cellular assays and noninvasive imaging.Complement yourself: Transcomplementation rescues partially folded mutant proteins.Infectious clones and vectors derived from adeno-associated virus (AAV) serotypes other than AAV type 2.Successful readministration of adeno-associated virus vectors to the mouse lung requires transient immunosuppression during the initial exposureRepeat transduction in the mouse lung by using adeno-associated virus vectors with different serotypesAdeno-associated virus type 5 (AAV5) but not AAV2 binds to the apical surfaces of airway epithelia and facilitates gene transfer.Repeated delivery of adeno-associated virus vectors to the rabbit airway.Concatamerization of adeno-associated virus circular genomes occurs through intermolecular recombination.Expression of human alpha1-antitrypsin in mice and dogs following AAV6 vector-mediated gene transfer to the lungs.Circulating anti-wild-type adeno-associated virus type 2 (AAV2) antibodies inhibit recombinant AAV2 (rAAV2)-mediated, but not rAAV5-mediated, gene transfer in the brain.Pseudotyped AAV vector-mediated gene transfer in a human fetal trachea xenograft model: implications for in utero gene therapy for cystic fibrosis.Intranasal vaccination with recombinant adeno-associated virus type 5 against human papillomavirus type 16 L1Sheep retrovirus structural protein induces lung tumoursProgress and prospects of gene therapy clinical trials for the muscular dystrophies.Adeno-associated virus vector mediated expression of an oncogenic retroviral envelope protein induces lung adenocarcinomas in immunocompetent mice.Capsid-expressing DNA in AAV vectors and its elimination by use of an oversize capsid gene for vector production.High-efficiency promoter-dependent transduction by adeno-associated virus type 6 vectors in mouse lung.Prevalence of neutralizing antibodies against adeno-associated virus (AAV) types 2, 5, and 6 in cystic fibrosis and normal populations: Implications for gene therapy using AAV vectors.Enhanced efficacy from gene therapy in Pompe disease using coreceptor blockadeImmunological aspects of recombinant adeno-associated virus delivery to the mammalian brainAdeno-associated virus serotype 9 vectors transduce murine alveolar and nasal epithelia and can be readministered.Current status of gene therapy for inherited lung diseasesOpposing functions of Akt isoforms in lung tumor initiation and progressionSystemic RNAi delivery to the muscles of ROSA26 mice reduces lacZ expressionIntranasal administration of adeno-associated virus type 12 (AAV12) leads to transduction of the nasal epithelia and can initiate transgene-specific immune responseAAV6-mediated systemic shRNA delivery reverses disease in a mouse model of facioscapulohumeral muscular dystrophyPreclinical Development of New Therapy for Glycogen Storage Diseases.
P2860
Q22008840-47D17118-B7A6-4877-BB61-66FC1F65EE09Q24523651-DCFFD6EF-888C-431B-81D1-17898B4C384DQ24529153-AA248130-FC21-428D-9E69-A64F9C7A70BCQ24634560-83735F94-F3CE-49DF-A1D7-AFA48155E029Q27661320-D16686A0-43A8-4A56-8D62-74BB3A14021AQ27673885-94B51F32-7F3E-4E47-AA0B-827CBA299EC7Q27681034-A114405A-E5C7-4514-B3F6-08A719E59E74Q33296224-A75DC004-0477-41EF-A0C7-12F11B70E6E6Q33374015-EBF9DA5F-CEE7-4E50-AC08-2C8DC589EC6DQ33586309-8BAAD50F-86DC-4A1E-933C-0B7BEA533BA6Q33695816-78B2A73C-A4A6-4F43-A8F7-C7285F8F426AQ33713348-FE51F100-3A1D-4B2B-92C0-CFB6790180A5Q33720634-345FBEC2-50D3-45C0-92CF-AD7EC8097B85Q33731159-8478C94D-6156-4AE3-91D5-8C3420C259C9Q33763709-D175D280-2225-4A2C-8A0A-E54C15E3D051Q33781976-52034AFC-CFF9-454A-8F5D-B83ACB333CDCQ33786029-9433CB3C-9643-4664-B096-D2A72C77520CQ33793801-87721B81-039F-4F24-9F0C-5DDD46E23AECQ33802811-16F1C627-8417-4295-ABF9-70E87252AB34Q33823405-5802AE79-215A-4D23-97CE-DA64239DDF31Q33823450-1FC5A120-773F-43F3-B3A5-679B1871F406Q33930149-1F6BC700-8150-4882-B636-29E0CDEFC3EBQ34193457-DDD7B965-885E-4859-8C9A-E7EEFC782568Q34399258-E797121C-C14C-4F5C-A2FF-E2D6D5C8E4F8Q34434903-4F35159A-4BD5-4821-8E19-2B9A64A18DB0Q34448401-0EEC168D-1233-4008-A438-EF24D51BE4C1Q34497471-32403C4C-9E52-4EB5-8A9A-E8CFA3D885D7Q34516556-B1A68A00-260C-4462-807E-F930100EF3EFQ34770593-34628315-FF63-453A-922C-054510F319D3Q34845196-766FB944-1682-45D3-B965-AE40612D442AQ34938807-D4F7452F-867E-4246-9E3D-308514BF2BFEQ34999729-748FBAF9-E712-4900-8E13-CABB89AF09DEQ35000819-97226B2E-21A6-4BD3-82BB-10741410BE8EQ35016463-D6347247-DA28-47B4-AF71-1503AFCCE1AEQ35043830-7D92F5C1-D86D-475F-9C2C-1206EC2966B8Q35145125-F9035A1C-FD38-4858-9911-21208C775448Q35225707-0C4DF320-AC67-4EE6-981F-8CBC9EF121EDQ35568518-1E8C0DBB-1864-4553-A4F7-DE82088B91A6Q35568525-A0852F1A-1A2E-490A-8246-3BC337453041Q35677604-404A3B47-2653-40F0-A13E-E9EE25E44A52
P2860
Transduction by adeno-associated virus vectors in the rabbit airway: efficiency, persistence, and readministration.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Transduction by adeno-associat ...... istence, and readministration.
@ast
Transduction by adeno-associat ...... istence, and readministration.
@en
type
label
Transduction by adeno-associat ...... istence, and readministration.
@ast
Transduction by adeno-associat ...... istence, and readministration.
@en
prefLabel
Transduction by adeno-associat ...... istence, and readministration.
@ast
Transduction by adeno-associat ...... istence, and readministration.
@en
P2093
P2860
P1433
P1476
Transduction by adeno-associat ...... sistence, and readministration
@en
P2093
A D Miller
C L Halbert
D W Russell
M L Aitken
T A Standaert
P2860
P304
P407
P577
1997-08-01T00:00:00Z